CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different
Open accessAbstract
Polyubiquitination of proteins has a pivotal role in the regulation of numerous cellular functions such as protein degradation, DNA repair and cell signaling. As deregulation of these processes can result in pathological conditions such as inflammatory diseases, neurodegeneration or cancer, tight regulation of the ubiquitin system is of tremendous importance. Ubiquitination by E3 ubiquitin ligases can be counteracted by the activity of several deubiquitinating enzymes (DUBs). CYLD, A20 and OTULIN have been implicated as key DUBs in the negative regulation of NF-κB transcription factor-mediated gene expression upon stimulation of cytokine receptors, antigen receptors and pattern recognition receptors, by removing distinct types of polyubiquitin chains from specific NF-κB signaling proteins. In addition, they control TNF-induced cell death signaling leading to apoptosis and necroptosis via similar mechanisms. In the case of A20, also catalytic-independent mechanisms of action have been demonstrated to have an important role. CYLD, A20 and OTULIN have largely overlapping substrates, suggesting at least partially redundant functions. However, mice deficient in one of the three DUBs show significant phenotypic differences, indicating also non-redundant functions. Here we discuss the activity and polyubiquitin chain-type specificity of CYLD, A20 and OTULIN, their specific role in NF-κB signaling and cell death, the molecular mechanisms that regulate their activity, their role in immune homeostasis and the association of defects in their activity with inflammation, autoimmunity and cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A20 inhibits CASP8 activation downstream of TRAILRs in glioblastoma cells, owing to its ability to polyubiquitinate RIPK1.
“In line with this notion, TNF alpha-induced protein 3 (TNFAIP3; best known as A20) inhibits CASP8 activation downstream of TRAILRs in glioblastoma cells, owing to its ability to polyubiquitinate RIPK1 [346, 347].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [347]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Komander, D., & Rape, M. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060310-170328 · Cited by 3,679 · see citing works
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O’Rourke, K. M., Zhou, H., Eby, M. T., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R. T., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,852 · see citing works
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409 · see citing works
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R., Wheeler, M. T., Tsui, C., Hurley, P. J., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,091 · see citing works
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,018 · see citing works
Hitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008) · Cell · doi:10.1016/j.cell.2008.10.044 · Cited by 989 · see citing works
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 964 · see citing works
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 947 · see citing works
Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., Vince, J. E., Warnken, U. H., Wenger, T., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.013 · Cited by 768 · see citing works
Identification of the familial cylindromatosis tumour-suppressor gene
Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H. E., BROWN, C. R., Biggs, P. J., Lakhani, S. R., et al. (2000) · Nature Genetics · doi:10.1038/76006 · Cited by 665 · see citing works
Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
Shembade, N., Ma, A. I., & Harhaj, E. W. (2010) · Science · doi:10.1126/science.1182364 · Cited by 644 · see citing works
Zhou, Q., Wang, H., Schwartz, D. M., Stoffels, M., Park, Y. H., Zhang, Y., Yang, D., Demirkaya, E., Takeuchi, M., Tsai, W. L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3459 · Cited by 643 · see citing works
Jin, Z., Li, Y., Pitti, R. M., Lawrence, D. A., Pham, V. C., Lill, J. R., & Ashkenazi, A. (2009) · Cell · doi:10.1016/j.cell.2009.03.015 · Cited by 588 · see citing works
Molecular discrimination of structurally equivalent Lys 63‐linked and linear polyubiquitin chains
Komander, D., Reyes‐Turcu, F. E., Licchesi, J. D. F., Odenwälder, P., Wilkinson, K. D., & Barford, D. (2009) · EMBO Reports · doi:10.1038/embor.2009.55 · Cited by 575 · see citing works
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
Walle, L., Opdenbosch, N. V., Jacques, P., Fossoul, A., Verheugen, E., Vogel, P., Beyaert, R., Elewaut, D., Kanneganti, T., van Loo, G., et al. (2014) · Nature · doi:10.1038/nature13322 · Cited by 499 · see citing works
Self-citationA20 in inflammation and autoimmunity
Catrysse, L., Vereecke, L., Beyaert, R., & Loo, G. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.10.005 · Cited by 494 · see citing works
Self-citationCaspase 8 inhibits programmed necrosis by processing CYLD
O’Donnell, M. A., Perez-Jimenez, E., Oberst, A., Ng, A., Massoumi, R., Xavier, R., Green, D. R., & Ting, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2362 · Cited by 494 · see citing works
OTULIN Antagonizes LUBAC Signaling by Specifically Hydrolyzing Met1-Linked Polyubiquitin
Keusekotten, K., Elliott, P. R., Glockner, L., Fiil, B. K., Damgaard, R. B., Kulathu, Y., Wauer, T., Hospenthal, M. K., Gyrd‐Hansen, M., Krappmann, D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.014 · Cited by 489 · see citing works
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Masoumi, K. C., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 480 · see citing works
Krikos, A., Laherty, C. D., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37138-8 · Cited by 444 · see citing works
Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z. J., Marynen, P., & Beyaert, R. (2008) · Nature Immunology · doi:10.1038/ni1561 · Cited by 437 · see citing works
Self-citationThe A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
Opipari, A. W., Hu, H., Yabkowitz, R., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42292-2 · Cited by 434 · see citing works
Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains
Emmerich, C. H., Ordureau, A., Strickson, S., Arthur, J. S. C., Pedrioli, P. G. A., Komander, D., & Cohen, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314715110 · Cited by 433 · see citing works
CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
Sun, S.-C. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.43 · Cited by 401 · see citing works
The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity
Damgaard, R. B., Nachbur, U., Yabal, M., Wong, W. W.-L., Fiil, B. K., Kastirr, M., Rieser, E., Rickard, J. A., Bankovacki, A., Peschel, C., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.014 · Cited by 379 · see citing works
Dixit, V. M., Green, S., Sarma, V. J., Holzman, L. B., Wolf, F. W., O’Rourke, K. M., Ward, P. A., Prochownik, E. V., & Marks, R. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39896-5 · Cited by 375 · see citing works
Rehman, S. A. A., Kristariyanto, Y. A., Choi, S., Nkosi, P. J., Weidlich, S., Labib, K. P. M., Hofmann, K., & Kulathu, Y. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.009 · Cited by 367 · see citing works
The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling
Ohtake, F., Saeki, Y., Ishido, S., Kanno, J., & Tanaka, K. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.014 · Cited by 350 · see citing works
Hitotsumatsu, O., Ahmad, R., Tavares, R. M., Wang, M., Philpott, D. J., Turer, E. E., Lee, B. L., Shiffin, N., Advincula, R., Malynn, B. A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.002 · Cited by 349 · see citing works
The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity
Damgaard, R. B., Walker, J. A., Marco-Casanova, P., Morgan, N. V., Titheradge, H. L., Elliott, P. R., McHale, D., Maher, E. R., McKenzie, A. N. J., & Komander, D. (2016) · Cell · doi:10.1016/j.cell.2016.07.019 · Cited by 348 · see citing works
Kim, S.-W., Ramasamy, K., Bouamar, H., Lin, A.-P., Jiang, D.-F., & Aguiar, R. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1200081109 · Cited by 336 · see citing works
Screening of DUB activity and specificity by MALDI-TOF mass spectrometry
Ritorto, M. S., Ewan, R., Pérez‐Oliva, A. B., Knebel, A., Buhrlage, S. J., Wightman, M., Kelly, S. M., Wood, N. T., Virdee, S., Gray, N. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5763 · Cited by 335 · see citing works
The tumour suppressor CYLD is a negative regulator of RIG‐I‐mediated antiviral response
Friedman, C. S., O’Donnell, M. A., Legarda, D., Ng, A., Cardenas, W. B., Yount, J. S., Moran, T. M., Basler, C. F., Komuro, A., Horvath, C. M., et al. (2008) · EMBO Reports · doi:10.1038/embor.2008.136 · Cited by 334 · see citing works
Moquin, D. M., McQuade, T., & Chan, F. K.-M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076841 · Cited by 320 · see citing works
Matmati, M., Jacques, P., Maelfait, J., Verheugen, E., Kool, M., Sze, M., Geboes, L., Louagie, E., Guire, C. M., Vereecke, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.874 · Cited by 288 · see citing works
Self-citationDráber, P., Kupka, S., Reichert, M., Draberova, H., Lafont, É., de Miguel, D., Spilgies, L. M., Šurinová, S., Taraborrelli, L., Hartwig, T., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.009 · Cited by 288 · see citing works
Onizawa, M., Oshima, S., Schulze-Topphoff, U., Oses-Prieto, J. A., Lu, T., Tavares, R., Prodhomme, T., Duong, B., Whang, M. I., Advincula, R., et al. (2015) · Nature Immunology · doi:10.1038/ni.3172 · Cited by 284 · see citing works
The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis
Rivkin, E., Almeida, S. M., Ceccarelli, D. F. J., Juang, Y.-C. A., MacLean, T. A., Srikumar, T., Huang, H., Dunham, W. H., Fukumura, R., ., G. X., et al. (2013) · Nature · doi:10.1038/nature12296 · Cited by 280 · see citing works
Shembade, N., Harhaj, N. S., Parvatiyar, K., Copeland, N. G., Jenkins, N. A., Matesic, L. E., & Harhaj, E. W. (2008) · Nature Immunology · doi:10.1038/ni1563 · Cited by 278 · see citing works
Vereecke, L., Sze, M., Guire, C. M., Rogiers, B., Chu, Y., Schmidt‐Supprian, M., Pasparakis, M., Beyaert, R., & Loo, G. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092474 · Cited by 278 · see citing works
Self-citationKomander, D., Lord, C. J., Scheel, H., Swift, S., Hofmann, K., Ashworth, A., & Barford, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.018 · Cited by 276 · see citing works
Zhou, Q., Yu, X., Demirkaya, E., Deuitch, N. T., Stone, D. L., Tsai, W. L., Kuehn, H. S., Wang, H., Yang, D., Park, Y. H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612594113 · Cited by 274 · see citing works
The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity
Tavares, R. M., Turer, E. E., Liu, C. L., Advincula, R., Scapini, P., Rhee, L., Barrera, J., Lowell, C. A., Utz, P. J., Malynn, B. A., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.017 · Cited by 271 · see citing works
Duong, B. H., Onizawa, M., Osés-Prieto, J. A., Advincula, R., Burlingame, A. L., Malynn, B. A., & Ma, A. I. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.031 · Cited by 269 · see citing works
OTULIN Restricts Met1-Linked Ubiquitination to Control Innate Immune Signaling
Fiil, B. K., Damgaard, R. B., Wagner, S., Keusekotten, K., Fritsch, M., Bekker‐Jensen, S., Mailand, N., Choudhary, C., Komander, D., & Gyrd‐Hansen, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.004 · Cited by 265 · see citing works
Regulation of NF‐κB by deubiquitinases
Harhaj, E. W., & Dixit, V. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01100.x · Cited by 260 · see citing works
Kool, M., Loo, G., Waelput, W., Prijck, S. D., Muskens, F., Sze, M., Praet, J. T. V., Branco‐Madeira, F., Janssens, S., Reizis, B., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.013 · Cited by 257 · see citing works
Self-citationReiley, W. W., Jin, W., Lee, A. J., Wright, A., Wu, X., Tewalt, E. F., Leonard, T. O., Norbury, C. C., Fitzpatrick, L. R., Zhang, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062694 · Cited by 255 · see citing works
Direct, Noncatalytic Mechanism of IKK Inhibition by A20
Skaug, B. A., Chen, J., Du, F., He, J., Ma, A. I., & Chen, Z. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.015 · Cited by 251 · see citing works
ABIN-1 Binds to NEMO/IKKγ and Co-operates with A20 in Inhibiting NF-κB
Mauro, C., Pacifico, F., Lavorgna, A., Mellone, S., Iannetti, A., Acquaviva, R., Formisano, S., Vito, P., & Leonardi, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601502200 · Cited by 250 · see citing works
Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation
Wertz, I. E., Newton, K., Seshasayee, D., Kusam, S., Lam, C., Zhang, J., Popovych, N., Helgason, E., Schoeffler, A. J., Jeet, S., et al. (2015) · Nature · doi:10.1038/nature16165 · Cited by 248 · see citing works
Zhang, J., Stirling, B., Temmerman, S. T., Ma, C. A., Fuss, I. J., Derry, J. M. J., & Jain, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28746 · Cited by 245 · see citing works
Hammer, G. E., Turer, E. E., Taylor, K. E., Fang, C. J., Advincula, R., Oshima, S., Barrera, J., Huang, E. J., Hou, B., Malynn, B. A., et al. (2011) · Nature Immunology · doi:10.1038/ni.2135 · Cited by 243 · see citing works
Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF‐κB regulation
Tokunaga, F., Nishimasu, H., Ishitani, R., Goto, E., Noguchi, T., Mio, K., Kamei, K., Ma, A. I., Iwaï, K., & Nureki, O. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.241 · Cited by 235 · see citing works
A20 Negatively Regulates T Cell Receptor Signaling to NF-κB by Cleaving Malt1 Ubiquitin Chains
Düwel, M., Welteke, V., Oeckinghaus, A., Baens, M., Kloo, B., Ferch, U., Darnay, B. G., Ruland, J., Marynen, P., & Krappmann, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803313 · Cited by 233 · see citing works
Evans, P. C., Ovaa, H., Hamon, M., Kilshaw, P. J., Hamm, S., Bauer, S., Ploegh, H. L., & Smith, T. (2004) · Biochemical Journal · doi:10.1042/bj20031377 · Cited by 229 · see citing works
Hutti, J. E., Shen, R. R., Abbott, D. W., Zhou, A. Y., Sprott, K. M., Asara, J. M., Hahn, W. C., & Cantley, L. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.031 · Cited by 229 · see citing works
Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins
Wagner, S., Carpentier, I., Rogov, V. V., Kreike, M., Ikeda, F., Löhr, F., Wu, C.-J., Ashwell, J. D., Dötsch, V., Đikić, I., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1211042 · Cited by 223 · see citing works
Self-citationT‐cell receptor‐induced JNK activation requires proteolytic inactivation of CYLD by MALT1
Staal, J., Driege, Y., Bekaert, T., Demeyer, A., Muyllaert, D., Damme, P. V., Gevaert, K., & Beyaert, R. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.85 · Cited by 221 · see citing works
Self-citationExpression, biological activities and mechanisms of action of A20 (TNFAIP3)
Verstrepen, L., Verhelst, K., Loo, G., Carpentier, I., Ley, S. C., & Beyaert, R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.044 · Cited by 219 · see citing works
Self-citationRegulation of T cell development by the deubiquitinating enzyme CYLD
Reiley, W. W., Zhang, M., Jin, W., Losiewicz, M. K., Donohue, K. B., Norbury, C. C., & Sun, S. (2006) · Nature Immunology · doi:10.1038/ni1315 · Cited by 216 · see citing works
Regulation of Early Wave of Germ Cell Apoptosis and Spermatogenesis by Deubiquitinating Enzyme CYLD
Wright, A., Reiley, W. W., Chang, M., Jin, W., Lee, A. J., Zhang, M., & Sun, S. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.09.007 · Cited by 212 · see citing works
The ubiquitin‐editing enzyme A20 requires RNF11 to downregulate NF‐κB signalling
Shembade, N., Parvatiyar, K., Harhaj, N. S., & Harhaj, E. W. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.285 · Cited by 211 · see citing works
Verhelst, K., Carpentier, I., Kreike, M., Meloni, L., Verstrepen, L., Kensche, T., Đikić, I., & Beyaert, R. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.240 · Cited by 203 · see citing works
Self-citationYoshida, H., Jono, H., Kai, H., & Li, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509526200 · Cited by 199 · see citing works
He, K., & Ting, A. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6034-6045.2002 · Cited by 196 · see citing works
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice
Jin, W., Chang, M., Paul, E. M., Babu, G. R., Lee, A. J., Reiley, W. W., Wright, A., Zhang, M., You, J., & Sun, S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34257 · Cited by 195 · see citing works
Regulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent Phosphorylation
Reiley, W. W., Zhang, M., Wu, X., Granger, E. L., & Sun, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.3886-3895.2005 · Cited by 193 · see citing works
Shembade, N., Harhaj, N. S., Liebl, D. J., & Harhaj, E. W. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601823 · Cited by 191 · see citing works
Ubiquitin Binding to A20 ZnF4 Is Required for Modulation of NF-κB Signaling
Bosanac, I., Wertz, I. E., Pan, B., Yu, C., Kusam, S., Lam, C., Phu, L., Phung, Q. T., Maurer, B., Arnott, D. P., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.009 · Cited by 190 · see citing works
Molecular Basis and Regulation of OTULIN-LUBAC Interaction
Elliott, P. R., Nielsen, S. V., Marco‐Casanova, P., Fiil, B. K., Keusekotten, K., Mailand, N., Freund, S. M. V., Gyrd‐Hansen, M., & Komander, D. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.018 · Cited by 185 · see citing works
Dimerization and Ubiquitin Mediated Recruitment of A20, a Complex Deubiquitinating Enzyme
Lu, T. T., Onizawa, M., Hammer, G. E., Turer, E. E., Yin, Q., Damko, E., Agelidis, A. M., Shifrin, N. T., Advincula, R., Barrera, J., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.008 · Cited by 185 · see citing works
NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB
Jono, H., Lim, J. H., Chen, L. F., Xu, H., Trompouki, E., Pan, Z. K., Mosialos, G., & Li, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406638200 · Cited by 180 · see citing works
Binding of OTULIN to the PUB Domain of HOIP Controls NF-κB Signaling
Schaeffer, V., Akutsu, M., Olma, M. H., Gomes, L. C., Kawasaki, M., & Đikić, I. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.016 · Cited by 179 · see citing works
Structure of the A20 OTU domain and mechanistic insights into deubiquitination
Komander, D., & Barford, D. (2007) · Biochemical Journal · doi:10.1042/bj20071399 · Cited by 170 · see citing works
Hutti, J. E., Turk, B. E., Asara, J. M., Ma, A. I., Cantley, L. C., & Abbott, D. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01101-07 · Cited by 169 · see citing works
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
Ahmed, N., Zeng, M., Sinha, I., Polin, L., Wei, W., Rathinam, C., Flavell, R. A., Massoumi, R., & Venuprasad, K. (2011) · Nature Immunology · doi:10.1038/ni.2157 · Cited by 160 · see citing works
Gringhuis, S. I., Kaptein, T. M., Wevers, B. A., Mesman, A. W., & Geijtenbeek, T. B. H. (2014) · Nature Communications · doi:10.1038/ncomms4898 · Cited by 158 · see citing works
SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
Elliott, P. R., Leske, D., Hrdinka, M., Bagola, K., Fiil, B. K., McLaughlin, S. H., Wagstaff, J. L., Volkmar, N., Christianson, J. C., Kessler, B. M., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.001 · Cited by 155 · see citing works
Inflammatory cardiac valvulitis in TAX1BP1‐deficient mice through selective NF‐κB activation
Iha, H., Péloponèse, J., Verstrepen, L., Zapart, G., Ikeda, F., Smith, C. D., Starost, M. F., Yedavalli, V. R. K., Heyninck, K., Đikić, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.5 · Cited by 154 · see citing works
Self-citationHrdinka, M., Fiil, B. K., Zucca, M., Leske, D., Bagola, K., Yabal, M., Elliott, P. R., Damgaard, R. B., Komander, D., Jost, P. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.062 · Cited by 151 · see citing works
A20 controls intestinal homeostasis through cell-specific activities
Vereecke, L., Vieira‐Silva, S., Billiet, T., van Es, J. H., Guire, C. M., Slowicka, K., Sze, M., van den Born, M., Hertogh, G. D., Clevers, H. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6103 · Cited by 136 · see citing works
Self-citationRegulation of A20 and other OTU deubiquitinases by reversible oxidation
Kulathu, Y., García, F., Mevissen, T. E. T., Busch, M., Arnaudo, N., Carroll, K. S., Barford, D., & Komander, D. (2013) · Nature Communications · doi:10.1038/ncomms2567 · Cited by 136 · see citing works
SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
Kupka, S., De Miguel, D., Draber, P., Martino, L., Surinova, S., Rittinger, K., & Walczak, H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.086 · Cited by 135 · see citing works
Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity
Sato, Y., Gotō, E., Shibata, Y., Kubota, Y., Yamagata, A., Goto‐Ito, S., Kubota, K., Inoue, J., Takekawa, M., Tokunaga, F., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2970 · Cited by 134 · see citing works
Wagner, S., Satpathy, S., Beli, P., & Choudhary, C. (2016) · The EMBO Journal · doi:10.15252/embj.201694300 · Cited by 128 · see citing works
Nikolaou, K., Tsagaratou, A., Eftychi, C., Kollias, G. A., Mosialos, G., & Talianidis, I. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.026 · Cited by 128 · see citing works
Ye, H., Liu, X., Lv, M., Wu, Y., Kuang, S., Gong, J., Yuan, P., Zhong, Z., Li, Q., Jia, H., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks175 · Cited by 126 · see citing works
The deubiquitinase activity of A20 is dispensable for NF‐κB signaling
De, A., Dainichi, T., Rathinam, C. V., & Ghosh, S. (2014) · EMBO Reports · doi:10.15252/embr.201338305 · Cited by 125 · see citing works
miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR
Balkhi, M. Y., Iwenofu, O. H., Bakkar, N., Ladner, K. J., Chandler, D. S., Houghton, P. J., London, C. A., Kraybill, W. G., Perrotti, D., Croce, C. M., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004177 · Cited by 119 · see citing works
A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma
Chanudet, E., Huang, Y., Ichimura, K., Dong, G., Hamoudi, R., Radford, J. A., Wotherspoon, A. C., Isaacson, P. G., Ferry, J. A., & Du, M. (2009) · Leukemia · doi:10.1038/leu.2009.234 · Cited by 117 · see citing works
CYLD: A Deubiquitination Enzyme with Multiple Roles in Cancer
Massoumi, R. (2011) · Future Oncology · doi:10.2217/fon.10.187 · Cited by 117 · see citing works
Takiuchi, T., Nakagawa, T., Tamiya, H., Fujita, H., Sasaki, Y., Saeki, Y., Takeda, H., Sawasaki, T., Buchberger, A., Kimura, T., et al. (2014) · Genes to Cells · doi:10.1111/gtc.12128 · Cited by 113 · see citing works
Optineurin Is Required for CYLD-Dependent Inhibition of TNFα-Induced NF-κB Activation
Nagabhushana, A., Bansal, M., & Swarup, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017477 · Cited by 111 · see citing works
Genetic relationships betweenA20/TNFAIP3, chronic inflammation and autoimmune disease
Vereecke, L., Beyaert, R., & Loo, G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391086 · Cited by 111 · see citing works
Self-citationSPATA2 promotes CYLD activity and regulates TNF‐induced NF‐κB signaling and cell death
Schlicher, L., Wissler, M., Preiss, F., Brauns‐Schubert, P., Jakob, C., Dumit, V. I., Borner, C., Dengjel, J., & Maurer, U. (2016) · EMBO Reports · doi:10.15252/embr.201642592 · Cited by 110 · see citing works
Takagi, M., Ogata, S., Ueno, H., Yoshida, K., Yeh, T., Hoshino, A., Piao, J., Yamashita, M., Nanya, M., Okano, T., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.038 · Cited by 105 · see citing works
The CAP-Gly Domain of CYLD Associates with the Proline-Rich Sequence in NEMO/IKKγ
Saito, K., Kigawa, T., Koshiba, S., Sato, K. Z., Matsuo, Y., Sakamoto, A., Takagi, T., Shirouzu, M., Yabuki, T., Nunokawa, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.07.012 · Cited by 103 · see citing works
Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
Hövelmeyer, N., Wunderlich, F. T., Massoumi, R., Jakobsen, C. G., Song, J., Wörns, M., Merkwirth, C., Kovalenko, A., Aumailley, M., Strand, D. J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070318 · Cited by 102 · see citing works
Legarda, D., Justus, S. J., Ang, R. L., Rikhi, N., Li, W., Moran, T. M., Zhang, J., Mizoguchi, E., Zelic, M., Kelliher, M. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.032 · Cited by 101 · see citing works
DUBs, the regulation of cell identity and disease
Heideker, J., & Wertz, I. E. (2014) · Biochemical Journal · doi:10.1042/bj20140496 · Cited by 100 · see citing works
Cleynen, I., Vazeille, E., Artieda, M., Verspaget, H. W., Szczypiorska, M., Bringer, M.-A., Lakatos, P. L., Seibold, F., Parnell, K. S., Weersma, R. K., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303205 · Cited by 99 · see citing works
CYLD-Mediated Signaling and Diseases
Mathis, B. J., Lai, Y., Qu, C., Janicki, J., & Cui, T. (2014) · Current Drug Targets · doi:10.2174/1389450115666141024152421 · Cited by 98 · see citing works
African-Derived Genetic Polymorphisms in TNFAIP3 Mediate Risk for Autoimmunity
Lodolce, J. P., Kolodziej, L. E., Rhee, L., Kariuki, S. N., Franek, B. S., McGreal, N. M., Logsdon, M. F., Bartulis, S. J., Perera, M. A., Ellis, N. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000324 · Cited by 97 · see citing works
A20 (Tnfaip3) Deficiency in Myeloid Cells Protects against Influenza A Virus Infection
Maelfait, J., Roose, K., Bogaert, P., Sze, M., Saelens, X., Pasparakis, M., Carpentier, I., Loo, G., & Beyaert, R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002570 · Cited by 91 · see citing works
Self-citationNovel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation
Won, M., Park, K. A., Byun, H. S., Sohn, K.-C., Kim, Y.-R., Jeon, J., Hong, J. H., Park, J., Seok, J. H., Kim, J., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.47 · Cited by 90 · see citing works
Wang, X., Deckert, M., Xuân, N. T., Nishanth, G., Just, S., Waisman, A., Naumann, M., & Schlüter, D. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1183-9 · Cited by 87 · see citing works
Shrikhande, G., Scali, S. T., da Silva, C. G., Damrauer, S. M., Csizmadia, E., Putheti, P., Matthey, M., Arjoon, R., Patel, R., Siracuse, J. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014240 · Cited by 85 · see citing works
Lippens, S., Lefebvre, S., Gilbert, B., Sze, M., Devos, M., Verhelst, K., Vereecke, L., Guire, C. M., Guérin, C. J., Vandenabeele, P., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.55 · Cited by 84 · see citing works
Self-citationJin, W., Reiley, W. W., Lee, A. J., Wright, A., Wu, X., Zhang, M., & Sun, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609952200 · Cited by 74 · see citing works
The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation
Rodriguez, M. S., Egaña, I., Lopitz‐Otsoa, F., Aillet, F., Lopez-Mato, M. P., Dorronsoro, A., Lobato-Gil, S., Sutherland, J. D., Barrio, R., Trigueros, C., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.366 · Cited by 54 · see citing works
A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection
Maelfait, J., Roose, K., Vereecke, L., Guire, C. M., Sze, M., Schuijs, M. J., Willart, M. A. M., Ibañez, L. I., Hammad, H., Lambrecht, B. N., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005410 · Cited by 53 · see citing works
Self-citationTruncation of the Catalytic Domain of the Cylindromatosis Tumor Suppressor Impairs Lung Maturation
Trompouki, E., Tsagaratou, A., Kosmidis, S., Dollé, P., Qian, J., Kontoyiannis, D. L., Cardoso, W. V., & Mosialos, G. (2009) · Neoplasia · doi:10.1593/neo.81424 · Cited by 51 · see citing works
Klei, L. R., Hu, D. G., Panek, R., Alfano, D. N., Bridwell, R. E., Bailey, K. M., Oravecz-Wilson, K. I., Concel, V. J., Hess, E. M., Beek, M. V., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.080 · Cited by 46 · see citing works
Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells
Kobayashi, T., Masoumi, K. C., & Massoumi, R. (2014) · Oncogene · doi:10.1038/onc.2014.159 · Cited by 45 · see citing works
Wang, S., Wen, F., Tessneer, K. L., & Gaffney, P. M. (2016) · Genes and Immunity · doi:10.1038/gene.2016.4 · Cited by 41 · see citing works
DUBs, the regulation of cell identity and disease
Heideker, J., & Wertz, I. E. (2015) · Biochemical Journal · doi:10.1042/bj4670191 · Cited by 40 · see citing works
Regulation of natural killer T‐cell development by deubiquitinase CYLD
Lee, A. J., Zhou, X., Chang, M., Hunzeker, J., Bonneau, R. H., Zhou, D., & Sun, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.31 · Cited by 40 · see citing works
NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20
Drennan, M. B., Govindarajan, S., Verheugen, E., Coquet, J. M., Staal, J., McGuire, C., Taghon, T., Leclercq, G., Beyaert, R., Loo, G., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151065 · Cited by 40 · see citing works
Self-citationThe Tumor Suppressor CYLD Controls the Function of Murine Regulatory T Cells
Reißig, S., Hövelmeyer, N., Weigmann, B., Nikolaev, A., Kalt, B., Wunderlich, T. F., Hahn, M., Neurath, M. F., & Waisman, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201993 · Cited by 38 · see citing works
A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-κB
Stilo, R., Varricchio, E., Liguoro, D., Leonardi, A., & Vito, P. (2008) · Journal of Cell Science · doi:10.1242/jcs.021105 · Cited by 38 · see citing works
Schworer, S. A., Smirnova, I., Валерьевна, К. И., Bagina, U., Churova, M. V., Fowler, T., Roy, A. L., Degterev, A., & Poltorak, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547547 · Cited by 37 · see citing works
The seventh zinc finger motif of A20 is required for the suppression of TNF‐α‐induced apoptosis
Yamaguchi, N., & Yamaguchi, N. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.022 · Cited by 31 · see citing works
Daniel, S., Patel, V. I., Shrikhande, G., Scali, S. T., Ramsey, H. E., Csizmadia, E., Benhaga, N., Fisher, M. D., Arvelo, M. B., & Ferran, C. J. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.167 · Cited by 28 · see citing works
IKK regulates the deubiquitinase CYLD at the postsynaptic density
Thein, S. H., Pham, A., Bayer, K. U., Tao-Cheng, J.-H., & Döṣemeci, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.019 · Cited by 27 · see citing works
Naturally occurring short splice variant of CYLD positively regulates dendritic cell function
Srokowski, C., Masri, J., Hövelmeyer, N., Krembel, A. K., Tertilt, C., Strand, D. J., Mahnke, K., Massoumi, R., Waisman, A., & Schild, H. (2009) · Blood · doi:10.1182/blood-2008-08-175489 · Cited by 27 · see citing works
SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination
Wu, X., Fukushima, H., North, B. J., Nagaoka, Y., Nagashima, K., Deng, F., Okabe, K., Inuzuka, H., & Wei, W. (2014) · Oncotarget · doi:10.18632/oncotarget.1971 · Cited by 25 · see citing works
Wex, K., Schmid, U., Just, S., Wang, X., Wurm, R., Naumann, M., Schlüter, D., & Nishanth, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00650 · Cited by 25 · see citing works
A20 and CYLD Do Not Share Significant Overlapping Functions during B Cell Development and Activation
Chu, Y., Soberon, V., Glockner, L., Beyaert, R., Massoumi, R., Loo, G., Krappmann, D., & Schmidt‐Supprian, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200396 · Cited by 24 · see citing works
Self-citationReißig, S., Hövelmeyer, N., Tang, Y., Weih, D., Nikolaev, A., Riemann, M., Weih, F., & Waisman, A. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2014.122 · Cited by 21 · see citing works
The role of A20 in the pathogenesis of lymphocytic malignancy
Zhang, F., Yang, L., & Li, Y. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-44 · Cited by 21 · see citing works
Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors
Jin, Y. J., Wang, S., Cho, J., Selim, M. A., Wright, T., Mosialos, G., & Zhang, J. Y. (2016) · JCI Insight · doi:10.1172/jci.insight.86548 · Cited by 18 · see citing works
A20: attractive without showing cleavage
Verhelst, K., Loo, G., & Beyaert, R. (2014) · EMBO Reports · doi:10.15252/embr.201439014 · Cited by 13 · see citing works
Self-citationΚαρατζάς, Δ., Xanthopoulos, K., Kotantaki, P., Pseftogas, A., Teliousis, K., Hatzivassiliou, E., Kontoyiannis, D. L., Poutahidis, T., & Mosialos, G. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0279-3 · Cited by 12 · see citing works
Arora, M., Kaul, D., Varma, N., & Marwaha, R. K. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.07.008 · Cited by 10 · see citing works
Guire, C. M., Rahman, M., Schwaninger, M., Beyaert, R., & Loo, G. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.55 · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,267 · see citing works
Death by TNF: a road to inflammation
Loo, G., & Bertrand, M. J. M. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00792-3 · Cited by 977 · see citing works
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome
Afonina, I. S., Zhong, Z., Karin, M., & Beyaert, R. (2017) · Nature Immunology · doi:10.1038/ni.3772 · Cited by 772 · see citing works
Self-citationNF-κB: At the Borders of Autoimmunity and Inflammation
Barnabei, L., Laplantine, E., Mbongo, W., Rieux‐Laucat, F., & Weil, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716469 · Cited by 641 · see citing works
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Basílio, J., Petzelbauer, P., Assinger, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00085 · Cited by 596 · see citing works
Ubiquitination in the regulation of inflammatory cell death and cancer
Cockram, P. E., Kist, M., Prakash, S., Chen, S., Wertz, I. E., & Vucic, D. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00708-5 · Cited by 520 · see citing works
Ubiquitin ligases in oncogenic transformation and cancer therapy
Senft, D., Qi, J., & Ronai, Z. A. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.105 · Cited by 490 · see citing works
Tumor immune evasion arises through loss of TNF sensitivity
Kearney, C. J., Vervoort, S. J., Hogg, S. J., Ramsbottom, K. M., Freeman, A. J., Lalaoui, N., Pijpers, L., Michie, J., Brown, K. K., Knight, D. A., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar3451 · Cited by 381 · see citing works
Dewson, G., Eichhorn, P. J. A., & Komander, D. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00633-y · Cited by 337 · see citing works
The therapeutic potential of targeting regulated non-apoptotic cell death
Hadian, K., & Stockwell, B. R. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00749-8 · Cited by 335 · see citing works
Cell death pathways: intricate connections and disease implications
Kist, M., & Vucic, D. (2021) · The EMBO Journal · doi:10.15252/embj.2020106700 · Cited by 328 · see citing works
NF-κB in monocytes and macrophages – an inflammatory master regulator in multitalented immune cells
Mußbacher, M., Derler, M., Basílio, J., & Schmid, J. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1134661 · Cited by 326 · see citing works
Human papillomavirus and the landscape of secondary genetic alterations in oral cancersPreprint
Gillison, M. L., Akagi, K., Xiao, W., Jiang, B., Pickard, R. K. L., Li, J., Swanson, B. J., Agrawal, A. D., Zucker, M., Stache-Crain, B., et al. (2018) · Genome Research · doi:10.1101/gr.241141.118 · Cited by 237 · see citing works
The double-edged functions of necroptosis
Ye, K., Chen, Z., & Xu, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05691-6 · Cited by 220 · see citing works
The RING finger protein family in health and disease
Cai, C., Tang, Y., Zhai, J., & Zheng, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01152-2 · Cited by 194 · see citing works
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
Mercogliano, M. F., Bruni, S., Elizalde, P. V., & Schillaci, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00584 · Cited by 186 · see citing works
Wei, W., Sun, J., Zhang, H., Xiao, X., Huang, C., Wang, L., Zhong, H., Jiang, Y., Zhang, X., & Jiang, G. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1518 · Cited by 177 · see citing works
Xiao, F., Zhang, D., Wu, Y., Jia, Q., Zhang, L., Li, Y., Yang, Y., Wang, H., Wu, C., & Wang, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.147 · Cited by 171 · see citing works
Polykratis, A., Martens, A., Eren, R. O., Shirasaki, Y., Yamagishi, M., Yamaguchi, Y., Uemura, S., Miura, M., Holzmann, B., Kollias, G. A., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0324-3 · Cited by 161 · see citing works
Vu, R., Jin, S., Sun, P., Haensel, D., Nguyen, Q., Dragan, M., Kessenbrock, K., Nie, Q. H., & Dai, X. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111155 · Cited by 149 · see citing works
Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death
Taft, J., Markson, M., Legarda, D., Patel, R., Chan, M., Malle, L., Richardson, A., Gruber, C., Martín-Fernández, M., Mancini, G. M. S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.026 · Cited by 151 · see citing works
A20 at the Crossroads of Cell Death, Inflammation, and AutoimmunityPreprint
Martens, A., & Loo, G. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036418 · Cited by 138 · see citing works
Cell death checkpoints in the TNF pathway
Huyghe, J., Priem, D., & Bertrand, M. J. M. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.05.007 · Cited by 143 · see citing works
K63 ubiquitination in immune signaling
Madiraju, C., Novack, J. P., Reed, J. C., & Matsuzawa, S. (2022) · Trends in Immunology · doi:10.1016/j.it.2021.12.005 · Cited by 136 · see citing works
The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways
Cohen, P., & Strickson, S. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.17 · Cited by 123 · see citing works
The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation
Hrdinka, M., & Gyrd‐Hansen, M. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.001 · Cited by 118 · see citing works
Nowak, A. J., & Relja, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249407 · Cited by 107 · see citing works
Deubiquitylating Enzymes in Cancer and Immunity
Ren, J., Yu, P., Liu, S., Li, R., Niu, X., Chen, Y., Zhang, Z., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202303807 · Cited by 107 · see citing works
OTUD4 Is a Phospho-Activated K63 Deubiquitinase that Regulates MyD88-Dependent Signaling
Zhao, Y. J., Mudge, M. C., Soll, J. M., Rodrigues, R. B., Byrum, A. K., Schwarzkopf, E. A., Bradstreet, T. R., Gygi, S. P., Edelson, B. T., & Mosammaparast, N. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.009 · Cited by 103 · see citing works
A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway
Quickelberghe, E. V., Sutter, D. D., Loo, G., Eyckerman, S., & Gevaert, K. (2018) · Scientific Data · doi:10.1038/sdata.2018.289 · Cited by 97 · see citing works
Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
Miraghazadeh, B., & Cook, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00613 · Cited by 96 · see citing works
Priem, D., Devos, M., Druwé, S., Martens, A., Slowicka, K., Ting, A. T., Pasparakis, M., Declercq, W., Vandenabeele, P., Loo, G., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1937-y · Cited by 95 · see citing works
He, R., Liu, Y., Fu, W., He, X., Liu, S., Xiao, D., & Tao, Y. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02172-y · Cited by 99 · see citing works
Linear ubiquitination at a glance
Spit, M., Rieser, E., & Walczak, H. (2019) · Journal of Cell Science · doi:10.1242/jcs.208512 · Cited by 94 · see citing works
Yang, X., Li, W., Zhang, S., Wu, D., Jiang, X., Tan, R., Niu, X., Wang, Q., Wu, X., Liu, Z., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2019102201 · Cited by 94 · see citing works
Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death
Clucas, J., & Meier, P. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00623-w · Cited by 92 · see citing works
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
Poondla, N., Chandrasekaran, A. P., Kim, K.-S., & Ramakrishna, S. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.3.048 · Cited by 87 · see citing works
Molecular Mechanisms of DUBs Regulation in Signaling and Disease
Li, Y., & Reverter, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030986 · Cited by 82 · see citing works
TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer
Siegmund, D., Wagner, J., & Wajant, H. (2022) · Cancers · doi:10.3390/cancers14164055 · Cited by 81 · see citing works
OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer
Damgaard, R. B., Jolin, H. E., Allison, M., Davies, S. E., Titheradge, H. L., McKenzie, A. N. J., & Komander, D. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0532-1 · Cited by 78 · see citing works
USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
Ren, Y., Feng, M., Hao, X., Liu, X., Li, J., Li, P., Gao, J., Qi, Q., Du, L., Wang, C., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1812 · Cited by 78 · see citing works
Mulas, F., Wang, X., Song, S., Nishanth, G., Yi, W., Brunn, A., Larsen, P., Isermann, B., Kalinke, U., Barragán, A., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0362-6 · Cited by 74 · see citing works
Oikawa, D., Gi, M., Kosako, H., Shimizu, K., Takahashi, H., Shiota, M., Hosomi, S., Komakura, K., Wanibuchi, H., Tsuruta, D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05145-5 · Cited by 75 · see citing works
At the Crossroads of TNF α Signaling and Cancer
Manohar, S. M. (2023) · Current Molecular Pharmacology · doi:10.2174/1874467217666230908111754 · Cited by 71 · see citing works
Transcriptional regulation of neutrophil differentiation and function during inflammation
Ai, Z.-C., & Udalova, I. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru1219-504rr · Cited by 55 · see citing works
OTULIN in NF-κB signaling, cell death, and disease
Verboom, L., Hoste, E., & Loo, G. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.05.003 · Cited by 60 · see citing works
Jiang, J., Luo, Y., Qin, W., Ma, H., Li, Q., Zhan, J., & Zhang, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00363 · Cited by 59 · see citing works
The Many Roles of Ubiquitin in NF-κB Signaling
Courtois, G., & Fauvarque, M. (2018) · Biomedicines · doi:10.3390/biomedicines6020043 · Cited by 58 · see citing works
CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression
Gu, Y., Wu, S., Fan, J., Meng, Z., Gao, G., Liu, T., Wang, Q., Xia, H., Wang, X., & Wu, K. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06464-5 · Cited by 57 · see citing works
CRISPR whole-genome screening identifies new necroptosis regulators and RIPK1 alternative splicing
Callow, M. G., Watanabe, C. K., Wickliffe, K. E., Bainer, R. O., Kummerfeld, S., Weng, J., Cuellar, T. L., Janakiraman, V., Chen, H., Chih, B., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0301-y · Cited by 54 · see citing works
Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures
Zhang, X., Zhang, P., Cong, A., Feng, Y., Chi, H., Xia, Z., & Tang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1264325 · Cited by 54 · see citing works
Cui, H., Rong, J., Chen, J., Jie, G., Zhu, J.-Q., Ruan, M., Zuo, R., Zhang, S., Qi, J., & Zhang, B. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i36.6079 · Cited by 53 · see citing works
The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics
Seo, J., Kim, M. W., Bae, K., Lee, S. C., Song, J., & Lee, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.012 · Cited by 47 · see citing works
The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases
Torabfam, G. Ç., Kesim, H., Ozer, E., & Kutlu, Ö. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176335 · Cited by 49 · see citing works
Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes
Doherty, L. M., Mills, C. E., Boswell, S. A., Liu, X., Hoyt, C. T., Gyori, B. M., Buhrlage, S. J., & Sorger, P. K. (2022) · eLife · doi:10.7554/elife.72879 · Cited by 47 · see citing works
Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
Chen, R., Pang, X., Li, L., Zeng, Z., Chen, M., & Zhang, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04566-6 · Cited by 48 · see citing works
Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders
Oikawa, D., Sato, Y., Ito, H., & Tokunaga, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093381 · Cited by 42 · see citing works
Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections
Chi, X., Huang, M., Tu, H., Zhang, B., Lin, X., Xu, H., Dong, C., & Hu, X. (2023) · Science China Life Sciences · doi:10.1007/s11427-021-2187-3 · Cited by 45 · see citing works
The emerging roles of non-canonical ubiquitination in proteostasis and beyond
Akizuki, Y., Kaypee, S., Ohtake, F., & Ikeda, F. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202311171 · Cited by 45 · see citing works
Deubiquitinases as novel therapeutic targets for diseases
Xian, Y., Ye, J., Tang, Y., Zhang, N., Peng, C. Y., Huang, W., & He, G. (2024) · MedComm · doi:10.1002/mco2.70036 · Cited by 49 · see citing works
Linear ubiquitin chain‐binding domains
Fennell, L. M., Rahighi, S., & Ikeda, F. (2018) · FEBS Journal · doi:10.1111/febs.14478 · Cited by 45 · see citing works
Yang, C., & Jiang, Q. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.013 · Cited by 45 · see citing works
Transcriptional and epigenetic regulation of immune tolerance: roles of the NF-κB family members
Zhang, L., Xiao, X., Arnold, P. R., & Li, X. C. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0202-8 · Cited by 44 · see citing works
Suenaga, N., Kuramitsu, M., Komure, K., Kanemaru, A., Takano, K., Ozeki, K., Nishimura, Y., Yoshida, R., Nakayama, H., Shinriki, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205194 · Cited by 44 · see citing works
Yan, B., Guo, J., Wang, Z., Ning, J., Wang, H., Shu, L., Hu, K., Chen, L., Shi, Y., Zhang, L., et al. (2023) · MedComm · doi:10.1002/mco2.337 · Cited by 41 · see citing works
The NF-κB signaling network in the life of T cells
Daniels, M., & Teixeiro, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1559494 · Cited by 44 · see citing works
Singh, A., Haque, M., O’Sullivan, K., Chourasia, M., Ouseph, M. M., & Ahmed, S. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0284-3 · Cited by 42 · see citing works
Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2
Chathuranga, K., Kim, T. H., Lee, H., Park, J., Kim, J., Chathuranga, W. A. G., Ekanayaka, P., Choi, Y. J., Lee, C., Kim, C., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020105139 · Cited by 41 · see citing works
Wu, Z., Berlemann, L. A., Bader, V., Sehr, D. A., Dawin, E., Covallero, A., Meschede, J., Angersbach, L., Showkat, C., Michaelis, J. B., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022112006 · Cited by 40 · see citing works
Borghi, A., Haegman, M., Fischer, R., Carpentier, I., Bertrand, M. J. M., Libert, C., Afonina, I. S., & Beyaert, R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.039 · Cited by 41 · see citing works
Self-citationYamanaka, S., Sato, Y., Oikawa, D., Gotō, E., Fukai, S., Tokunaga, F., Takahashi, H., & Sawasaki, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.12.049 · Cited by 41 · see citing works
Emerging Roles and Research Tools of Atypical Ubiquitination
Huang, Q., & Zhang, X. (2020) · PROTEOMICS · doi:10.1002/pmic.201900100 · Cited by 41 · see citing works
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
Lork, M., Staal, J., & Beyaert, R. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2018.11.001 · Cited by 39 · see citing works
Self-citationOPTN recruitment to a Golgi-proximal compartment regulates immune signalling and cytokine secretion
O’Loughlin, T. A., Kruppa, A. J., Ribeiro, A. L. R., Edgar, J. R., Ghannam, A., Smith, A. M., & Buß, F. (2020) · Journal of Cell Science · doi:10.1242/jcs.239822 · Cited by 40 · see citing works
LUBAC-mediated linear ubiquitination: a crucial regulator of immune signaling
IWAI, K. (2021) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.97.007 · Cited by 37 · see citing works
TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms
Huber, R., Bikker, R., Welz, B., Christmann, M., & Brand, K. (2017) · Journal of Immunology Research · doi:10.1155/2017/9570129 · Cited by 37 · see citing works
MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell death
Fu, B., Lin, X., Tan, S., Zhang, R., Xue, W., Zhang, H., Zhang, S., Zhao, Q., Wang, Y., Feldman, K. A., et al. (2021) · EMBO Reports · doi:10.15252/embr.202052252 · Cited by 35 · see citing works
Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma
Shinriki, S., Jono, H., Maeshiro, M., Nakamura, T., Guo, J., Li, J., Ueda, M., Yoshida, R., Shinohara, M., Nakayama, H., et al. (2017) · The Journal of Pathology · doi:10.1002/path.5019 · Cited by 36 · see citing works
Su, Y., Shi, P., Zhang, L., Lu, D., Zhao, C., Li, R., Zhang, L., & Huang, J. (2018) · Journal of Virology · doi:10.1128/jvi.00175-18 · Cited by 36 · see citing works
Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson’s disease
Pirooznia, S. K., Wang, H., Panicker, N., Kumar, M., Neifert, S., Dar, M. A., Lau, E., Kang, B. G., Redding‐Ochoa, J., Troncoso, J. C., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh1824 · Cited by 34 · see citing works
Gong, P., Davidson, G. A., Gui, W., Yang, K., Bozza, W. P., & Zhuang, Z. (2018) · Chemical Science · doi:10.1039/c8sc01573b · Cited by 34 · see citing works
Feng, J., Wang, H., Jing, Z., Wang, Y., Wang, W., Jiang, Y., & Sun, W. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.626909 · Cited by 35 · see citing works
Impact of bacterial infection and intestinal microbiome on colorectal cancer development
Sun, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001979 · Cited by 33 · see citing works
Mechanistic insights into the protective impact of zinc on sepsis
Souffriau, J., & Libert, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.12.002 · Cited by 31 · see citing works
Roles of protein ubiquitination in inflammatory bowel disease
Xiao, Y., Huang, Q. Q., Wu, Z., & Chen, W. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.152026 · Cited by 31 · see citing works
Mechanism and Disease Association With a Ubiquitin Conjugating E2 Enzyme: UBE2L3
Zhang, X., Huo, C., Liu, Y., Su, R., Zhao, Y., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.793610 · Cited by 31 · see citing works
Notch1 signaling contributes to TLR4-triggered NF-κB activation in macrophages
Li, L., Jin, J., Liu, H., Ma, X.-F., Wang, D., Song, Y., Wang, C., Jiang, J., Yan, G., Qin, X., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153894 · Cited by 31 · see citing works
Cui, Z., Kang, H., Grandis, J. R., & Johnson, D. E. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0565 · Cited by 30 · see citing works
Role of ubiquitination and proteolysis in the regulation of pro- and anti-apoptotic TNF-R1 signaling
Fritsch, J. H., Zingler, P., Särchen, V., Heck, A. L., & Schütze, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.07.017 · Cited by 29 · see citing works
Roles of Ubiquitination and Deubiquitination in Regulating Dendritic Cell Maturation and Function
Zhu, B., Zhu, L., Xia, L., Xiong, Y., Yin, Q., & Rui, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586613 · Cited by 29 · see citing works
Jiang, H., Zhang, C., Lin, M., Yin, Y., Deng, S., Liu, W., Zhuo, B., Tian, G., Du, Y., & Meng, Z. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102536 · Cited by 32 · see citing works
Genetic Testing in CYLD Cutaneous Syndrome: An Update
Nagy, N., Dubois, A., Széll, M., & Rajan, N. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s288274 · Cited by 28 · see citing works
Colombo, E., Horta, G., Roesler, M. K., Ihbe, N., Chhabra, S., Radyushkin, K., Liberto, G. D., Kreutzfeldt, M., Schumann, S., von Engelhardt, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110755118 · Cited by 28 · see citing works
From death to birth: how osteocyte death promotes osteoclast formation
Zhao, W., Qian, J., Li, J., Su, T., Deng, X., Fu, Y., Liang, X., & Cui, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551542 · Cited by 26 · see citing works
The role of deubiquitinating enzymes in gastric cancer (Review)
Sun, J., Shi, X., Mamun, M., & Gao, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.11062 · Cited by 27 · see citing works
Fuseya, Y., & Iwaï, K. (2021) · Cells · doi:10.3390/cells10102706 · Cited by 25 · see citing works
Chavoshinezhad, S., Beirami, E., Izadpanah, E., Feligioni, M., & Hassanzadeh, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115656 · Cited by 27 · see citing works
Mendelian diseases of dysregulated canonical NF-κB signaling: From immunodeficiency to inflammation
Schnappauf, O., & Aksentijevich, I. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr0520-166r · Cited by 28 · see citing works
Li, X., Yao, Y., Wang, S., & Xu, S. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.11.007 · Cited by 26 · see citing works
- Authors
- Lork, M., Verhelst, K., & Beyaert, R.
- Affiliations
- Ghent University (BE)
- Corresponding author
- Beyaert, Rudi
- Venue
- Cell Death & Differentiation
- Published
- 2017-03-31
- Volume
- 24
- Issue
- 7
- Pages
- 1172-1183
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC5520167
- OpenAlex
- W2600455045
- Cited by
- 282
- References
- 136
- Citations by year
- 2026: 26 · 2025: 18 · 2024: 37 · 2023: 27 · 2022: 33 · 2021: 51 · 2020: 33 · 2019: 21 · 2018: 22 · 2017: 14
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- Fondation contre le Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- CYLD, A20, OTULIN, deubiquitinase, NF-κB signaling, TNF-induced cell death, apoptosis, necroptosis, E3 ubiquitin ligase, immune homeostasis, inflammation, autoimmunity, cancer, ubiquitination
- MeSH terms
- Deubiquitinating Enzymes, Animals, Humans, Models, Biological, Signal Transduction, NF-kappa B, Cell Death, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review